INVO Bioscience, Inc.

NASDAQ (USD): INVO Bioscience, Inc. (INVO)

Last Price

0.84

Today's Change

-0.05 (5.61%)

Day's Change

0.782 - 0.94

Trading Volume

121,578

Profile
INVO

Exchange:  NASDAQ Capital Market NASDAQ Capital Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Steven M. Shum Mr. Steven M. Shum

Full Time Employees:  25 25

IPO Date:  2020-11-02 2020-11-02

CIK:  0001417926 0001417926

ISIN:  US44984F4019 US44984F4019

CUSIP:  44984F302 44984F302

Beta:  1.49 1.49

Last Dividend:  0.00 0.00

Dcf Diff:  0.00 0.00

Dcf:  0.00 0.00

Description

INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

Address

5582 Broadcast Court,
Sarasota, FL 34240, US

978 878 9505

http://www.invobio.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment